We recognize that significant compounding of tirzepatide injection products is occurring, and that some number of patients currently receiving those products can be expected to seek Lillys approved products at a future point when compounding is curtailed
Today's study therefore specifically investigates the effect of semaglutide compared to placebo in patients with CKD and T2D
Always follow the specific Instructions for Use (IFU) provided with your medication, as techniques may vary between products
Frequency changes alone do not indicate an excessive dose and often appear during early adjustment
Several important safety considerations from the SmPC should be noted: If pancreatitis is suspected, Ozempic should be discontinued immediately and urgent medical assessment sought Patients should be counselled about gallbladder disease symptoms, as GLP-1 receptor agonists may increase the risk of gallstones [14] Those with pre-existing diabetic retinopathy should be monitored for potential worsening, particularly during rapid improvement in glucose control If a patient is taking warfarin or other coumarin derivatives, more frequent INR monitoring is recommended when starting Ozempic [1] Before initiating Ozempic in patients with known liver conditions, healthcare professionals should conduct a thorough assessment of liver disease severity, review concurrent medications for potential interactions, and establish baseline liver function tests
